![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TAOK1 |
Gene summary for TAOK1 |
![]() |
Gene information | Species | Human | Gene symbol | TAOK1 | Gene ID | 57551 |
Gene name | TAO kinase 1 | |
Gene Alias | KFC-B | |
Cytomap | 17q11.2 | |
Gene Type | protein-coding | GO ID | GO:0000075 | UniProtAcc | A0A024QZ70 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
57551 | TAOK1 | N_HPV_1 | Human | Cervix | N_HPV | 8.53e-05 | -1.53e-01 | 0.0079 |
57551 | TAOK1 | CCI_1 | Human | Cervix | CC | 2.34e-02 | 5.47e-01 | 0.528 |
57551 | TAOK1 | CCI_3 | Human | Cervix | CC | 7.65e-04 | 5.70e-01 | 0.516 |
57551 | TAOK1 | HTA11_866_3004761011 | Human | Colorectum | AD | 1.98e-03 | -4.05e-01 | 0.096 |
57551 | TAOK1 | HTA11_6818_2000001021 | Human | Colorectum | AD | 2.32e-02 | -3.58e-01 | 0.0588 |
57551 | TAOK1 | F007 | Human | Colorectum | FAP | 1.48e-02 | -2.64e-01 | 0.1176 |
57551 | TAOK1 | A002-C-010 | Human | Colorectum | FAP | 2.62e-03 | -1.99e-01 | 0.242 |
57551 | TAOK1 | A015-C-203 | Human | Colorectum | FAP | 2.03e-32 | -4.08e-01 | -0.1294 |
57551 | TAOK1 | A015-C-204 | Human | Colorectum | FAP | 3.44e-08 | -3.99e-01 | -0.0228 |
57551 | TAOK1 | A014-C-040 | Human | Colorectum | FAP | 8.25e-07 | -5.98e-01 | -0.1184 |
57551 | TAOK1 | A002-C-201 | Human | Colorectum | FAP | 1.34e-13 | -4.09e-01 | 0.0324 |
57551 | TAOK1 | A002-C-203 | Human | Colorectum | FAP | 1.96e-04 | -1.96e-01 | 0.2786 |
57551 | TAOK1 | A001-C-119 | Human | Colorectum | FAP | 2.19e-07 | -7.70e-04 | -0.1557 |
57551 | TAOK1 | A001-C-108 | Human | Colorectum | FAP | 1.19e-19 | -2.54e-01 | -0.0272 |
57551 | TAOK1 | A002-C-205 | Human | Colorectum | FAP | 4.24e-23 | -3.31e-01 | -0.1236 |
57551 | TAOK1 | A001-C-104 | Human | Colorectum | FAP | 1.80e-04 | -2.53e-01 | 0.0184 |
57551 | TAOK1 | A015-C-005 | Human | Colorectum | FAP | 8.18e-05 | -2.63e-01 | -0.0336 |
57551 | TAOK1 | A015-C-006 | Human | Colorectum | FAP | 4.52e-16 | -4.35e-01 | -0.0994 |
57551 | TAOK1 | A015-C-106 | Human | Colorectum | FAP | 2.66e-15 | -3.22e-01 | -0.0511 |
57551 | TAOK1 | A002-C-114 | Human | Colorectum | FAP | 8.20e-20 | -3.90e-01 | -0.1561 |
Page: 1 2 3 4 5 6 7 8 9 10 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:003297010 | Cervix | CC | regulation of actin filament-based process | 96/2311 | 397/18723 | 4.00e-11 | 8.54e-09 | 96 |
GO:190290310 | Cervix | CC | regulation of supramolecular fiber organization | 92/2311 | 383/18723 | 1.49e-10 | 2.48e-08 | 92 |
GO:003295610 | Cervix | CC | regulation of actin cytoskeleton organization | 86/2311 | 358/18723 | 5.90e-10 | 7.51e-08 | 86 |
GO:003367410 | Cervix | CC | positive regulation of kinase activity | 101/2311 | 467/18723 | 8.66e-09 | 7.22e-07 | 101 |
GO:00458608 | Cervix | CC | positive regulation of protein kinase activity | 85/2311 | 386/18723 | 5.61e-08 | 3.29e-06 | 85 |
GO:00447725 | Cervix | CC | mitotic cell cycle phase transition | 89/2311 | 424/18723 | 2.70e-07 | 1.12e-05 | 89 |
GO:00310988 | Cervix | CC | stress-activated protein kinase signaling cascade | 58/2311 | 247/18723 | 8.02e-07 | 2.89e-05 | 58 |
GO:00719007 | Cervix | CC | regulation of protein serine/threonine kinase activity | 75/2311 | 359/18723 | 2.76e-06 | 8.02e-05 | 75 |
GO:00514038 | Cervix | CC | stress-activated MAPK cascade | 55/2311 | 239/18723 | 2.96e-06 | 8.31e-05 | 55 |
GO:00703027 | Cervix | CC | regulation of stress-activated protein kinase signaling cascade | 46/2311 | 195/18723 | 9.35e-06 | 2.11e-04 | 46 |
GO:00073466 | Cervix | CC | regulation of mitotic cell cycle | 88/2311 | 457/18723 | 1.26e-05 | 2.60e-04 | 88 |
GO:19019903 | Cervix | CC | regulation of mitotic cell cycle phase transition | 63/2311 | 299/18723 | 1.27e-05 | 2.60e-04 | 63 |
GO:00719025 | Cervix | CC | positive regulation of protein serine/threonine kinase activity | 46/2311 | 200/18723 | 1.87e-05 | 3.47e-04 | 46 |
GO:19029048 | Cervix | CC | negative regulation of supramolecular fiber organization | 40/2311 | 167/18723 | 2.39e-05 | 4.17e-04 | 40 |
GO:00434104 | Cervix | CC | positive regulation of MAPK cascade | 90/2311 | 480/18723 | 2.92e-05 | 4.83e-04 | 90 |
GO:00328727 | Cervix | CC | regulation of stress-activated MAPK cascade | 44/2311 | 192/18723 | 3.09e-05 | 5.10e-04 | 44 |
GO:00602498 | Cervix | CC | anatomical structure homeostasis | 63/2311 | 314/18723 | 6.03e-05 | 8.68e-04 | 63 |
GO:002241110 | Cervix | CC | cellular component disassembly | 83/2311 | 443/18723 | 6.04e-05 | 8.68e-04 | 83 |
GO:00106399 | Cervix | CC | negative regulation of organelle organization | 68/2311 | 348/18723 | 7.40e-05 | 1.03e-03 | 68 |
GO:19019873 | Cervix | CC | regulation of cell cycle phase transition | 74/2311 | 390/18723 | 9.80e-05 | 1.27e-03 | 74 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa040109 | Cervix | CC | MAPK signaling pathway | 62/1267 | 302/8465 | 4.89e-03 | 1.67e-02 | 9.86e-03 | 62 |
hsa0401012 | Cervix | CC | MAPK signaling pathway | 62/1267 | 302/8465 | 4.89e-03 | 1.67e-02 | 9.86e-03 | 62 |
hsa04010 | Colorectum | FAP | MAPK signaling pathway | 68/1404 | 302/8465 | 4.00e-03 | 1.67e-02 | 1.02e-02 | 68 |
hsa040101 | Colorectum | FAP | MAPK signaling pathway | 68/1404 | 302/8465 | 4.00e-03 | 1.67e-02 | 1.02e-02 | 68 |
hsa040102 | Colorectum | CRC | MAPK signaling pathway | 56/1091 | 302/8465 | 2.76e-03 | 1.77e-02 | 1.20e-02 | 56 |
hsa040103 | Colorectum | CRC | MAPK signaling pathway | 56/1091 | 302/8465 | 2.76e-03 | 1.77e-02 | 1.20e-02 | 56 |
hsa0401014 | Oral cavity | OSCC | MAPK signaling pathway | 165/3704 | 302/8465 | 7.11e-05 | 2.74e-04 | 1.40e-04 | 165 |
hsa0401015 | Oral cavity | OSCC | MAPK signaling pathway | 165/3704 | 302/8465 | 7.11e-05 | 2.74e-04 | 1.40e-04 | 165 |
hsa0401023 | Oral cavity | EOLP | MAPK signaling pathway | 68/1218 | 302/8465 | 7.48e-05 | 3.40e-04 | 2.01e-04 | 68 |
hsa0401033 | Oral cavity | EOLP | MAPK signaling pathway | 68/1218 | 302/8465 | 7.48e-05 | 3.40e-04 | 2.01e-04 | 68 |
hsa0401041 | Oral cavity | NEOLP | MAPK signaling pathway | 59/1112 | 302/8465 | 9.40e-04 | 4.67e-03 | 2.94e-03 | 59 |
hsa0401051 | Oral cavity | NEOLP | MAPK signaling pathway | 59/1112 | 302/8465 | 9.40e-04 | 4.67e-03 | 2.94e-03 | 59 |
hsa0401010 | Prostate | BPH | MAPK signaling pathway | 87/1718 | 302/8465 | 2.05e-04 | 1.13e-03 | 6.98e-04 | 87 |
hsa0401013 | Prostate | BPH | MAPK signaling pathway | 87/1718 | 302/8465 | 2.05e-04 | 1.13e-03 | 6.98e-04 | 87 |
hsa0401022 | Prostate | Tumor | MAPK signaling pathway | 87/1791 | 302/8465 | 8.46e-04 | 3.94e-03 | 2.45e-03 | 87 |
hsa0401032 | Prostate | Tumor | MAPK signaling pathway | 87/1791 | 302/8465 | 8.46e-04 | 3.94e-03 | 2.45e-03 | 87 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TAOK1 | SNV | Missense_Mutation | novel | c.338N>T | p.Ser113Leu | p.S113L | Q7L7X3 | protein_coding | deleterious(0) | probably_damaging(0.986) | TCGA-95-A4VN-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TAOK1 | SNV | Missense_Mutation | c.2266G>T | p.Val756Phe | p.V756F | Q7L7X3 | protein_coding | tolerated(0.07) | benign(0.319) | TCGA-L9-A7SV-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Chemotherapy | cisplatin | CR | |
TAOK1 | SNV | Missense_Mutation | c.649G>C | p.Glu217Gln | p.E217Q | Q7L7X3 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-18-3410-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
TAOK1 | SNV | Missense_Mutation | c.376N>A | p.Val126Met | p.V126M | Q7L7X3 | protein_coding | tolerated(0.12) | benign(0.015) | TCGA-43-6647-01 | Lung | lung squamous cell carcinoma | Female | >=65 | I/II | Chemotherapy | taxol | CR | |
TAOK1 | SNV | Missense_Mutation | c.2522N>A | p.Arg841Gln | p.R841Q | Q7L7X3 | protein_coding | deleterious(0) | benign(0.399) | TCGA-43-6771-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
TAOK1 | SNV | Missense_Mutation | novel | c.1792N>A | p.Glu598Lys | p.E598K | Q7L7X3 | protein_coding | deleterious(0.01) | probably_damaging(0.995) | TCGA-56-8201-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
TAOK1 | SNV | Missense_Mutation | c.805N>G | p.Arg269Gly | p.R269G | Q7L7X3 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-66-2789-01 | Lung | lung squamous cell carcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD | |
TAOK1 | SNV | Missense_Mutation | c.1304N>T | p.Arg435Leu | p.R435L | Q7L7X3 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-85-6561-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Chemotherapy | cisplatin | SD | |
TAOK1 | SNV | Missense_Mutation | novel | c.885G>T | p.Gln295His | p.Q295H | Q7L7X3 | protein_coding | deleterious(0.04) | benign(0.007) | TCGA-85-8355-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
TAOK1 | SNV | Missense_Mutation | novel | c.137N>A | p.Arg46Gln | p.R46Q | Q7L7X3 | protein_coding | tolerated(0.13) | possibly_damaging(0.514) | TCGA-90-A4ED-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
57551 | TAOK1 | SERINE THREONINE KINASE, KINASE, DRUGGABLE GENOME, DNA REPAIR, ENZYME | PHA-767491 | CHEMBL225519 | ||
57551 | TAOK1 | SERINE THREONINE KINASE, KINASE, DRUGGABLE GENOME, DNA REPAIR, ENZYME | PF-562271 | PF-00562271 | ||
57551 | TAOK1 | SERINE THREONINE KINASE, KINASE, DRUGGABLE GENOME, DNA REPAIR, ENZYME | TAE-684 | TAE-684 | ||
57551 | TAOK1 | SERINE THREONINE KINASE, KINASE, DRUGGABLE GENOME, DNA REPAIR, ENZYME | ENTRECTINIB | ENTRECTINIB | ||
57551 | TAOK1 | SERINE THREONINE KINASE, KINASE, DRUGGABLE GENOME, DNA REPAIR, ENZYME | LY-2090314 | LY-2090314 | ||
57551 | TAOK1 | SERINE THREONINE KINASE, KINASE, DRUGGABLE GENOME, DNA REPAIR, ENZYME | CENISERTIB | CENISERTIB | ||
57551 | TAOK1 | SERINE THREONINE KINASE, KINASE, DRUGGABLE GENOME, DNA REPAIR, ENZYME | DNDI1417467 | CHEMBL1997335 | ||
57551 | TAOK1 | SERINE THREONINE KINASE, KINASE, DRUGGABLE GENOME, DNA REPAIR, ENZYME | BMS-387032 | BMS-387032 | ||
57551 | TAOK1 | SERINE THREONINE KINASE, KINASE, DRUGGABLE GENOME, DNA REPAIR, ENZYME | LINIFANIB | LINIFANIB | ||
57551 | TAOK1 | SERINE THREONINE KINASE, KINASE, DRUGGABLE GENOME, DNA REPAIR, ENZYME | BMS-345541 | BMS-345541 |
Page: 1 2 3 4 |